Business
BioLife Solutions Awarded Three New Patents for Cell and Gene Therapy Bioproduction Tools
Expanded Intellectual Property Related to 2019 Acquisitions of Astero Bio and SAVSU Technologies BOTHELL, Wash., March 2, 2020 /PRNewswire/ -- BioLife
About this update from Biolife Solutions, Inc.
[{"type":"text","content":"Expanded Intellectual Property Related to 2019 Acquisitions of Astero Bio and SAVSU Technologies\n\n\nBOTHELL, Wash., March 2, 2020 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, today announced three new patents for bioproduction tools related to the 2019 acquisitions of Astero Bio and SAVSU Technologies. The new patents awarded to BioLife include:\n\n \n \n\n \nUnited States Patent: Contents Rack for Use in Insulated Storage Containers \nThis patent covers the key technologies used in the -80°C dry ice evo® smart shipping container, currently in use by Novartis to transport the AveXis ZOLGENSMA® gene therapy. The evo platform was acquired from SAVSU Technologies in August 2019.\nJapan Patent: Systems, Devices, and Methods for Automated Sample Thawing\nThis patent covers core technologies used in the ThawSTAR® automated, water-free thaw products acquired from Astero Bio in April 2019.\nUnited States Patent: Biologic Stability, Delivery Logistics and Administration of Time and/or Temperature Sensitive Biologic Based Materials \nThis patent covers core features in the evo.is cloud application that enables real-time tracking and monitoring of high-value shipments of cell and gene therapies.\nMike Rice, BioLife Solutions CEO, remarked, \"We have a remarkably strong team of inventors who are experts in the fields of cryopreservation, storage and transport, and thawing of biologic material. Our portfolio now includes a synergistic family of risk-mitigating bioproduction tools, including our CryoStor® and HypoThermosol® biopreservation media, ThawSTAR automated, water-free thawing products, evo platform of smart, cloud-connected shipping containers and the evo.is cloud app, and Custom Biogenic Systems high capacity freezers, racks and accessories. We look forward to providing a continuous stream of innovative solutions to the high growth cell and gene therapy market.\" \nAbout BioLife Solutions\nBioLife Solutions is a leading supplier of cell and gene therapy bioproduction tools. Our tools portfolio includes our proprietary CryoStor® freeze media and HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, and Custom Biogenic Systems high capacity s...